Published on Monday September 06, 2021

We are working on the following new projects:

  • We are preparing a contract for a phase 1 clinical trial with Dalteparin sodium.
  • Our company signed a contract signature for the observational program with a top ten pharma.

We are happy to reach the following milestones in our projects:

  • We received the Council of Ethics approval in the trial with COVID-19 vaccine.
  • The enrollment was finished in the Spasmoanalgesic trial.
  • The screening was performed in the Ibuprofen trial.